Research Article

You have full text access to this OnlineOpen article

Predictors and outcomes of scleroderma renal crisis: The high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial

  1. Paul J. DeMarco1,
  2. Michael H. Weisman2,
  3. James R. Seibold3,
  4. Daniel E. Furst4,
  5. Weng Kee Wong5,
  6. Eric L. Hurwitz5,
  7. Maureen Mayes6,
  8. Barbara White7,
  9. Fredrick Wigley8,
  10. Walter Barr9,
  11. Larry Moreland10,
  12. Thomas A. Medsger Jr.11,
  13. Virginia Steen12,
  14. Richard W. Martin13,
  15. David Collier14,
  16. Arthur Weinstein15,
  17. Edward Lally16,
  18. John Varga17,
  19. Steven R. Weiner4,
  20. Brian Andrews18,
  21. Micha Abeles19,
  22. Philip J. Clements4,*

Article first published online: 8 NOV 2002

DOI: 10.1002/art.10589

Issue

Arthritis & Rheumatism

Arthritis & Rheumatism

Volume 46, Issue 11, pages 2983–2989, November 2002

Additional Information

How to Cite

DeMarco, P. J., Weisman, M. H., Seibold, J. R., Furst, D. E., Wong, W. K., Hurwitz, E. L., Mayes, M., White, B., Wigley, F., Barr, W., Moreland, L., Medsger, T. A., Steen, V., Martin, R. W., Collier, D., Weinstein, A., Lally, E., Varga, J., Weiner, S. R., Andrews, B., Abeles, M. and Clements, P. J. (2002), Predictors and outcomes of scleroderma renal crisis: The high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial. Arthritis & Rheumatism, 46: 2983–2989. doi: 10.1002/art.10589

Author Information

  1. 1

    Marshfield Clinic, Wausau, Wisconsin

  2. 2

    Cedars–Sinai Medical Center, Los Angeles, California

  3. 3

    University of Medicine and Dentistry of New Jersey–Robert Wood Johnson Medical School, New Brunswick

  4. 4

    University of California, Los Angeles, School of Medicine

  5. 5

    University of California, Los Angeles, School of Public Health

  6. 6

    University of Texas, Houston

  7. 7

    University of Maryland School of Medicine, Baltimore

  8. 8

    The Johns Hopkins University, Baltimore, Maryland

  9. 9

    Northwestern University Medical School, Chicago, Illinois

  10. 10

    University of Alabama at Birmingham

  11. 11

    University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

  12. 12

    Georgetown University Medical Center, Washington, DC

  13. 13

    Michigan State University College of Human Medicine, Grand Rapids

  14. 14

    University of Colorado Health Sciences Center, Denver

  15. 15

    George Washington University Medical Center, Washington, DC

  16. 16

    Brown University School of Medicine, Roger Williams General Hospital, Providence, Rhode Island

  17. 17

    University of Illinois, Chicago

  18. 18

    University of California, Irvine

  19. 19

    University of Connecticut Health Center, Farmington

*University of California, Los Angeles, School of Medicine, 32-59 Rehabilitation Building, 1000 Veteran Avenue, Los Angeles, CA 90095-1670

Publication History

  1. Issue published online: 8 NOV 2002
  2. Article first published online: 8 NOV 2002
  3. Manuscript Accepted: 15 JUL 2002
  4. Manuscript Received: 8 JAN 2002

Funded by

  • Scleroderma Federation
  • United Scleroderma Foundation
  • FDA Orphan Drug Program
  • Arthritis Foundation
  • CRC. Grant Numbers: M01-RR-00865, M01-RR-00827
  • Winifred Krause
  • Morris Goldsmith
  • Takako Ito

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (86K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    B Galarraga, S McSwiggan, FR Caswell, RC Brodie, P Sharma, EW Abel, DJ Newton, JJF Belch, A novel approach to measuring skin elasticity in systemic sclerosis: results from a pilot study, Scandinavian Journal of Rheumatology, 2011, 40, 3, 211

    CrossRef

  2. 2
    Chitra Hosing, Richard Nash, Peter McSweeney, Shin Mineishi, James Seibold, Linda M. Griffith, Howard Shulman, Ellen Goldmuntz, Maureen Mayes, Chirag R. Parikh, Leslie Crofford, Lynette Keyes-Elstein, Daniel Furst, Virginia Steen, Keith M. Sullivan, Acute Kidney Injury in Patients with Systemic Sclerosis Participating in Hematopoietic Cell Transplantation Trials in the United States, Biology of Blood and Marrow Transplantation, 2011, 17, 5, 674

    CrossRef

  3. 3
    Chi-hong Tseng, Weng Kee Wong, Analysis of a composite endpoint with longitudinal and time-to-event data, Statistics in Medicine, 2011, 30, 9
    Direct Link:
  4. 4
    Binh Nguyen, Maureen D. Mayes, Frank C. Arnett, Deborah del Junco, John D. Reveille, Emilio B. Gonzalez, Hilda T. Draeger, Marilyn Perry, Amir Hendiani, Kiran K. Anand, Shervin Assassi, HLA–DRB1*0407 and *1304 are risk factors for scleroderma renal crisis, Arthritis & Rheumatism, 2011, 63, 2
    Direct Link:
  5. 5
    Guillaume Bussone, Luc Mouthon, Interstitial lung disease in systemic sclerosis, Autoimmunity Reviews, 2011, 10, 5, 248

    CrossRef

  6. 6
    Guillaume Bussone, Laure-Hélène Noël, Luc Mouthon, Manifestations rénales de la sclérodermie systémique, Néphrologie & Thérapeutique, 2011, 7, 3, 192

    CrossRef

  7. 7
    Francesco Zulian, James T. Cassidy, Textbook of Pediatric Rheumatology, 2011,

    CrossRef

  8. 8
    Akitaka SHIBATA, Akinori HAYAKAWA, Teruyuki MITSUMA, ANCA-related Crescentic Glomerulonephritis in a Patient with Scleroderma: A Case Report, Nishi Nihon Hifuka, 2010, 72, 1, 6

    CrossRef

  9. 9
    Gerald Trang, Russell Steele, Murray Baron, Marie Hudson, Corticosteroids and the risk of scleroderma renal crisis: a systematic review, Rheumatology International, 2010,

    CrossRef

  10. 10
    Mandana Nikpour, Wendy M. Stevens, Ariane L. Herrick, Susanna M. Proudman, Epidemiology of systemic sclerosis, Best Practice & Research Clinical Rheumatology, 2010, 24, 6, 857

    CrossRef

  11. 11
    Dinesh Khanna, Christopher P. Denton, Evidence-based management of rapidly progressing systemic sclerosis, Best Practice & Research Clinical Rheumatology, 2010, 24, 3, 387

    CrossRef

  12. 12
    B Ranque, A Bérezné, V Le-Guern, C Pagnoux, Y Allanore, D Launay, E Hachulla, F-J Authier, R Gherardi, A Kahan, J Cabane, L Guillevin, L Mouthon, Myopathies related to systemic sclerosis: a case–control study of associated clinical and immunological features, Scandinavian Journal of Rheumatology, 2010, 39, 6, 498

    CrossRef

  13. 13
    Guillaume Bussone, Alice Bérezné, Vincent Pestre, Loïc Guillevin, Luc Mouthon, The Scleroderma Kidney: Progress in Risk Factors, Therapy, and Prevention, Current Rheumatology Reports, 2010, 13, 1, 37

    CrossRef

  14. 14
    Luc Mouthon, Alice Bérezné, Loïc Guillevin, Dominique Valeyre, Therapeutic options for systemic sclerosis related interstitial lung diseases, Respiratory Medicine, 2010, 104, S59

    CrossRef

  15. 15
    Mary E. Margaretten, Lawrence M. Tierney, Gurpreet Dhaliwal, A Hard Diagnosis, New England Journal of Medicine, 2009, 361, 6, 613

    CrossRef

  16. 16
    T. Schmeiser, U. Müller-Ladner, EULAR-Empfehlungen zur Behandlung der systemischen Sklerose, Zeitschrift für Rheumatologie, 2009, 69, 1, 87

    CrossRef

  17. 17
    C. P. Denton, G. Lapadula, L. Mouthon, U. Muller-Ladner, Renal complications and scleroderma renal crisis, Rheumatology, 2009, 48, Supplement 3, iii32

    CrossRef

  18. 18
    Luc Mouthon, Alice Bérezné, Guillaume Bussone, Laure-Hélène Noël, Peter M. Villiger, Loïc Guillevin, Scleroderma Renal Crisis: A Rare but Severe Complication of Systemic Sclerosis, Clinical Reviews in Allergy & Immunology, 2009, 40, 2, 84

    CrossRef

  19. 19
    Hadim Akoglu, Gokhan Kadir Atılgan, Ramazan Ozturk, Ezgi Coskun Yenigun, Ipek Isık Gonul, Ali Rıza Odabas, A “silent” course of normotensive scleroderma renal crisis: case report and review of the literature, Rheumatology International, 2008, 29, 10, 1223

    CrossRef

  20. 20
    Henry Penn, Christopher P Denton, Diagnosis, management and prevention of scleroderma renal disease, Current Opinion in Rheumatology, 2008, 20, 6, 692

    CrossRef

  21. 21
    Z. Nagy, Z. Balint, H. Farkas, J. Radics, G. Kumanovics, T. Minier, C. Varju, L. Czirjak, Establishment and partial validation of a patient skin self-assessment questionnaire in systemic sclerosis, Rheumatology, 2008, 48, 3, 309

    CrossRef

  22. 22
    C. P. Denton, Renal manifestations of systemic sclerosis--clinical features and outcome assessment, Rheumatology, 2008, 47, Supplement 5, v54

    CrossRef

  23. 23
    Francesco Zulian, Systemic Sclerosis and Localized Scleroderma in Childhood, Rheumatic Disease Clinics of North America, 2008, 34, 1, 239

    CrossRef

  24. 24
    Y Oyama, W G Barr, L Statkute, T Corbridge, E A Gonda, B Jovanovic, A Testori, R K Burt, Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis, Bone Marrow Transplantation, 2007, 40, 6, 549

    CrossRef

  25. 25
    Yannick Allanore, Jèrôme Avouac, Julien Wipff, André Kahan, New therapeutic strategies in the management of systemic sclerosis, Expert Opinion on Pharmacotherapy, 2007, 8, 5, 607

    CrossRef

  26. 26
    Paolo Airo’, Mirko Scarsi, Mara Rossi, Michele Mondini, Onset and enhancement of systemic sclerosis after treatments for multiple sclerosis, Rheumatology International, 2007, 28, 7, 703

    CrossRef

  27. 27
    Lynne Shand, Mark Lunt, Svetlana Nihtyanova, Mansour Hoseini, Alan Silman, Carol M. Black, Christopher P. Denton, Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: Application of a latent linear trajectory model, Arthritis & Rheumatism, 2007, 56, 7
    Direct Link:
  28. 28
    G. Riemekasten, D. Dragun, Risikoadaptierte Therapien bei der systemischen Sklerose, Zeitschrift für Rheumatologie, 2007, 66, 8, 672

    CrossRef

  29. 29
    Hany G. Bashandy, Jason S. Javillo, Steven R. Gambert, A Case of Early Onset Normotensive Scleroderma Renal Crisis in a Patient with Diffuse Cutaneous Systemic Sclerosis, Southern Medical Journal, 2006, 99, 8, 870

    CrossRef

  30. 30
    O. Nadashkevich, P. Davis, M. Fritzler, W. Kovalenko, A randomized unblinded trial of cyclophosphamide versus azathioprine in the treatment of systemic sclerosis, Clinical Rheumatology, 2006, 25, 2, 205

    CrossRef

  31. 31
    Carmen Fonseca, Elizabeth Renzoni, Piersante Sestini, Panagiotis Pantelidis, Anna Lagan, Christopher Bunn, Neil McHugh, Ken I. Welsh, Ron M. Du Bois, Christopher P. Denton, Carol Black, D. Abraham, Endothelin axis polymorphisms in patients with scleroderma, Arthritis & Rheumatism, 2006, 54, 9
    Direct Link:
  32. 32
    Mayumi HIROTA, Yoshinao MURO, Yasushi TOMITA, Limited Cutaneous Systemic Sclerosis with Rapid Progression of Edematous Stiffness on the Forearms, Nishi Nihon Hifuka, 2006, 68, 1, 24

    CrossRef

  33. 33
    Christopher P Denton, Carol M Black, David J Abraham, Mechanisms and consequences of fibrosis in systemic sclerosis, Nature Clinical Practice Rheumatology, 2006, 2, 3, 134

    CrossRef

  34. 34
    C. Sunderkötter, G. Riemekasten, Raynaud-Phänomen in der Dermatologie, Der Hautarzt, 2006, 57, 10, 927

    CrossRef

  35. 35
    Thomas A. Medsger, Tatiana S. Rodriguez-Reyna, Scleroderma Renal Crisis: A High Index of Suspicion Speeds Diagnosis and Life-saving Treatment, Southern Medical Journal, 2006, 99, 8, 799

    CrossRef

  36. 36
    S. Kleinert, H. P. Tony, C. Kneitz, Systemische Sklerose, Der Internist, 2006, 47, 10, 1051

    CrossRef

  37. 37
    G. Riemekasten, H. Schulze-Koops, Medikament�se vasoaktive Therapien von Mikrozirkulationsst�rungen bei rheumatischen Erkrankungen, Zeitschrift f�r Rheumatologie, 2005, 64, 2, 123

    CrossRef

  38. 38
    Elisa Y. Rhew, Walter G. Barr, Scleroderma renal crisis: New insights and developments, Current Rheumatology Reports, 2004, 6, 2, 129

    CrossRef

  39. 39
    Panagiota I. Latsi, Athol U. Wells, Evaluation and management of alveolitis and interstitial lung disease in scleroderma, Current Opinion in Rheumatology, 2003, 15, 6, 748

    CrossRef

  40. 40
    Vibeke Strand, Predictors and outcomes of scleroderma renal crisis: Data from the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial, Arthritis & Rheumatism, 2002, 46, 11
    Direct Link:
View Full Article (HTML) Get PDF (86K)